Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study Academic Article uri icon

Overview

MeSH Major

  • Immunologic Factors
  • Interferon-beta
  • Multiple Sclerosis, Relapsing-Remitting
  • Peptides

abstract

  • These observations demonstrate that treating physicians use both clinical and MRI parameters to define a response to treatment and initiation of a treatment change and that baseline MRI identified those with increased risk of treatment failure.

publication date

  • September 15, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.jns.2009.04.020

PubMed ID

  • 19428028

Additional Document Info

start page

  • 116

end page

  • 9

volume

  • 284

number

  • 1-2